UNH | ||
---|---|---|
OUTLOOK RATING 1..100 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 14 Undervalued | |
PROFIT vs RISK RATING 1..100 | 85 | |
SMR RATING 1..100 | 40 | |
PRICE GROWTH RATING 1..100 | 65 | |
P/E GROWTH RATING 1..100 | 97 | |
SEASONALITY SCORE 1..100 | 95 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
CURE | UNH | |
---|---|---|
RSI ODDS (%) | N/A | 4 days ago74% |
Stochastic ODDS (%) | 4 days ago88% | 4 days ago62% |
Momentum ODDS (%) | 4 days ago90% | 4 days ago52% |
MACD ODDS (%) | 4 days ago88% | 4 days ago57% |
TrendWeek ODDS (%) | 4 days ago90% | 4 days ago52% |
TrendMonth ODDS (%) | 4 days ago90% | 4 days ago45% |
Advances ODDS (%) | 5 days ago90% | 5 days ago53% |
Declines ODDS (%) | 25 days ago90% | 12 days ago52% |
BollingerBands ODDS (%) | 4 days ago90% | 4 days ago50% |
Aroon ODDS (%) | N/A | 4 days ago41% |
A.I.dvisor indicates that over the last year, UNH has been closely correlated with HUM. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if UNH jumps, then HUM could also see price increases.